Active Psychology & Behaviour Brain & Nervous System

Bridging the Neurocomputational Explanations of Paranoia: From Cognition to Clinic

In plain English

AI plain-English summary

Paranoia warps how the brain interprets social interactions, and researchers will now induce it temporarily in healthy volunteers using THC—the psychoactive compound in cannabis—to map the neural shift from trust to suspicion. Current treatments for paranoia often miss the mark because scientists do not fully understand how the brain processes social cues during paranoid states. This project fills that gap by combining interactive social tasks, mathematical models, and brain imaging. By comparing THC-induced paranoia in healthy people with data from patients experiencing persecutory delusions, the team can isolate the neural and computational signatures of paranoia across the full spectrum—from neurotransmitter activity to real-world clinical symptoms. If successful, the work will produce a free, browser-based platform called Hypatia, where researchers worldwide can test new models and therapies. This could lead to treatments that directly target the social brain mechanisms underlying paranoia, rather than relying on broad antipsychotic drugs. The research is primarily fundamental science—decoding how the brain encodes threat in social contexts—but similar foundational work on fear circuits has already reshaped anxiety treatments. A deeper understanding of paranoia’s neural basis could eventually reduce the isolation and distress that millions of patients experience daily.

View original technical description
Paranoia, a persistent and distressing symptom of psychosis, involves the fear and belief that others intend harm. It significantly impacts patients, causing distress and isolation. Yet, the science often overlooks how the brain encodes social interaction, critical to understanding paranoia. This gap limits the development of effective therapies directly addressing patient concerns. Our goal is to change this. We will decode how the brain maps social interactions using advanced interactive paradigms, mathematical models, and neuroimaging. By administering THC, the psychoactive component in cannabis, to healthy volunteers we will induce temporary, reversable paranoia. This allows us to study the shift into paranoid states and compare the findings with data from individuals receiving clinical support for persecutory delusions. EXE will be involved in all stages of the research from designing, advising to dissemination of the findings. Our research will cover the spectrum from neurotransmitters to neurons and computational markers to clinical settings. We will share our results freely, and integrate our models into the free, browser based Hypatia platform, fostering the international development of new tools and therapies. This work aims to lay a foundation for innovative treatments and support options for those suffering from severe paranoia.

View the original record at the funder ↗

Researchers

Amir Englund (EPMC Awardee)Joseph Barnby (EPMC Awardee)Michael Moutoussis (EPMC Awardee)Mitul Mehta (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Pathways to psychosis among cannabis users
STOP- Successful Treatment Of Paranoia: Replacing harmful paranoid thoughts with better alternatives
Pathway to Psychosis among cannabis users: The Cannabis&Me study
Understanding and treating persecutory delusions: an interventionist-causal model approach
A randomised controlled trial to evaluate the outcomes and mechanisms of a novel digital reasoning intervention for persecutory delusions

Original classification

Applying neuroscience to understand symptoms in anxiety, depression & psychosis

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.